Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -3.38 Million USD | 60.81% |
| 2023 | -8.63 Million USD | -90.35% |
| 2022 | -4.53 Million USD | -75.88% |
| 2021 | -2.57 Million USD | 62.39% |
| 2020 | -6.85 Million USD | -898.79% |
| 2019 | -686.78 Thousand USD | 43.0% |
| 2018 | -1.2 Million USD | 1.68% |
| 2017 | -1.22 Million USD | 35.12% |
| 2016 | -1.88 Million USD | -73.57% |
| 2015 | -1.08 Million USD | 27.88% |
| 2014 | -1.5 Million USD | 38.9% |
| 2013 | -2.46 Million USD | -138.78% |
| 2012 | -1.03 Million USD | -8.44% |
| 2011 | -953.88 Thousand USD | 2.14% |
| 2010 | -974.7 Thousand USD | 35.68% |
| 2009 | -1.51 Million USD | 16.18% |
| 2008 | -1.8 Million USD | -430.96% |
| 2007 | -340.45 Thousand USD | -322.06% |
| 2006 | 153.31 Thousand USD | 23.44% |
| 2005 | 124.2 Thousand USD | 454.31% |
| 2004 | -35.05 Thousand USD | 83.4% |
| 2003 | -211.19 Thousand USD | -289.59% |
| 2002 | 111.39 Thousand USD | 12.86% |
| 2001 | 98.7 Thousand USD | 120.81% |
| 2000 | -474.21 Thousand USD | 68.39% |
| 1999 | -1.5 Million USD | 11.76% |
| 1998 | -1.7 Million USD | -30.77% |
| 1997 | -1.3 Million USD | -750.0% |
| 1996 | 200 Thousand USD | -66.67% |
| 1995 | 600 Thousand USD | -40.0% |
| 1994 | 1 Million USD | -47.37% |
| 1993 | 1.9 Million USD | -5.0% |
| 1992 | 2 Million USD | -20.0% |
| 1991 | 2.5 Million USD | -10.71% |
| 1990 | 2.8 Million USD | 0.0% |
| 1989 | - USD | 100.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -3.38 Million USD | 60.81% |
| 2024 Q4 | -3.38 Million USD | 24.05% |
| 2024 Q3 | -4.45 Million USD | 28.08% |
| 2024 Q1 | -6.97 Million USD | 19.22% |
| 2024 Q2 | -6.19 Million USD | 11.18% |
| 2023 Q2 | -3.81 Million USD | 19.79% |
| 2023 Q1 | -4.76 Million USD | -4.91% |
| 2023 FY | -8.63 Million USD | -90.35% |
| 2023 Q4 | -8.63 Million USD | -298.6% |
| 2023 Q3 | -2.16 Million USD | 43.25% |
| 2022 Q1 | -3.43 Million USD | -33.06% |
| 2022 Q4 | -4.53 Million USD | 48.03% |
| 2022 FY | -4.53 Million USD | -75.88% |
| 2022 Q2 | -5.69 Million USD | -65.96% |
| 2022 Q3 | -8.73 Million USD | -53.25% |
| 2021 Q4 | -2.57 Million USD | 29.27% |
| 2021 FY | -2.57 Million USD | 62.39% |
| 2021 Q1 | -5.23 Million USD | 23.72% |
| 2021 Q2 | -4 Million USD | 23.46% |
| 2021 Q3 | -3.64 Million USD | 8.93% |
| 2020 FY | -6.85 Million USD | -898.79% |
| 2020 Q1 | 1.11 Million USD | 262.88% |
| 2020 Q2 | 1.02 Million USD | -8.11% |
| 2020 Q3 | -561.24 Thousand USD | -154.6% |
| 2020 Q4 | -6.85 Million USD | -1122.2% |
| 2019 Q1 | -583.69 Thousand USD | 51.56% |
| 2019 Q3 | -917.93 Thousand USD | 18.4% |
| 2019 FY | -686.78 Thousand USD | 43.0% |
| 2019 Q4 | -686.78 Thousand USD | 25.18% |
| 2019 Q2 | -1.12 Million USD | -92.72% |
| 2018 Q1 | -1.08 Million USD | 11.79% |
| 2018 Q4 | -1.2 Million USD | -101.82% |
| 2018 Q3 | -597.03 Thousand USD | 27.0% |
| 2018 Q2 | -817.81 Thousand USD | 24.35% |
| 2018 FY | -1.2 Million USD | 1.68% |
| 2017 Q4 | -1.22 Million USD | 20.51% |
| 2017 FY | -1.22 Million USD | 35.12% |
| 2017 Q1 | -1.81 Million USD | 3.81% |
| 2017 Q2 | -1.61 Million USD | 11.33% |
| 2017 Q3 | -1.54 Million USD | 4.31% |
| 2016 Q4 | -1.88 Million USD | -119.86% |
| 2016 Q3 | -859.14 Thousand USD | -33.62% |
| 2016 Q2 | -642.97 Thousand USD | 28.02% |
| 2016 FY | -1.88 Million USD | -73.57% |
| 2016 Q1 | -893.26 Thousand USD | 17.92% |
| 2015 FY | -1.08 Million USD | 27.88% |
| 2015 Q2 | -1.67 Million USD | -1.64% |
| 2015 Q4 | -1.08 Million USD | 7.12% |
| 2015 Q3 | -1.17 Million USD | 30.01% |
| 2015 Q1 | -1.64 Million USD | -9.13% |
| 2014 FY | -1.5 Million USD | 38.9% |
| 2014 Q4 | -1.5 Million USD | 9.4% |
| 2014 Q2 | -1.64 Million USD | 21.0% |
| 2014 Q1 | -2.08 Million USD | 15.56% |
| 2014 Q3 | -1.66 Million USD | -1.1% |
| 2013 Q2 | -1.19 Million USD | 8.09% |
| 2013 Q1 | -1.29 Million USD | -25.63% |
| 2013 FY | -2.46 Million USD | -138.78% |
| 2013 Q4 | -2.46 Million USD | -6.52% |
| 2013 Q3 | -2.31 Million USD | -94.13% |
| 2012 Q3 | -898.45 Thousand USD | 5.84% |
| 2012 Q1 | -996.99 Thousand USD | -4.52% |
| 2012 FY | -1.03 Million USD | -8.44% |
| 2012 Q2 | -954.22 Thousand USD | 4.29% |
| 2012 Q4 | -1.03 Million USD | -15.12% |
| 2011 FY | -953.88 Thousand USD | 2.14% |
| 2011 Q1 | -743.41 Thousand USD | 23.73% |
| 2011 Q2 | -913.72 Thousand USD | -22.91% |
| 2011 Q3 | -857.11 Thousand USD | 6.2% |
| 2011 Q4 | -953.88 Thousand USD | -11.29% |
| 2010 Q2 | -1.35 Million USD | 17.55% |
| 2010 Q1 | -1.64 Million USD | -8.84% |
| 2010 FY | -974.7 Thousand USD | 35.68% |
| 2010 Q3 | -1.03 Million USD | 23.62% |
| 2010 Q4 | -974.7 Thousand USD | 6.16% |
| 2009 Q1 | -1.8 Million USD | 0.09% |
| 2009 Q4 | -1.51 Million USD | -8.64% |
| 2009 FY | -1.51 Million USD | 16.18% |
| 2009 Q2 | -1.69 Million USD | 6.0% |
| 2009 Q3 | -1.39 Million USD | 17.84% |
| 2008 Q2 | -482.03 Thousand USD | 41.92% |
| 2008 Q3 | -514.09 Thousand USD | -6.65% |
| 2008 Q4 | -1.8 Million USD | -251.63% |
| 2008 FY | -1.8 Million USD | -430.96% |
| 2008 Q1 | -830.01 Thousand USD | -143.8% |
| 2007 Q2 | 214.25 Thousand USD | 25.52% |
| 2007 Q4 | -340.45 Thousand USD | -291.81% |
| 2007 Q1 | 170.69 Thousand USD | 11.34% |
| 2007 FY | -340.45 Thousand USD | -322.06% |
| 2007 Q3 | 177.5 Thousand USD | -17.15% |
| 2006 Q4 | 153.31 Thousand USD | -30.45% |
| 2006 Q1 | 93.32 Thousand USD | -24.86% |
| 2006 Q2 | 698.71 Thousand USD | 648.7% |
| 2006 Q3 | 220.42 Thousand USD | -68.45% |
| 2006 FY | 153.31 Thousand USD | 23.44% |
| 2005 Q3 | 291.68 Thousand USD | 19.6% |
| 2005 FY | 124.2 Thousand USD | 454.31% |
| 2005 Q2 | 243.88 Thousand USD | 38.41% |
| 2005 Q1 | 176.2 Thousand USD | 602.63% |
| 2005 Q4 | 124.2 Thousand USD | -57.42% |
| 2004 Q3 | -76.99 Thousand USD | -388.94% |
| 2004 FY | -35.05 Thousand USD | 83.4% |
| 2004 Q2 | 26.64 Thousand USD | -47.24% |
| 2004 Q1 | 50.5 Thousand USD | 123.92% |
| 2004 Q4 | -35.05 Thousand USD | 54.47% |
| 2003 Q3 | -251.41 Thousand USD | -47.93% |
| 2003 Q1 | 67.37 Thousand USD | -39.51% |
| 2003 Q2 | -169.96 Thousand USD | -352.26% |
| 2003 Q4 | -211.19 Thousand USD | 16.0% |
| 2003 FY | -211.19 Thousand USD | -289.59% |
| 2002 Q1 | 235.63 Thousand USD | 138.74% |
| 2002 Q2 | 378.91 Thousand USD | 60.81% |
| 2002 Q3 | 308.31 Thousand USD | -18.63% |
| 2002 Q4 | 111.39 Thousand USD | -63.87% |
| 2002 FY | 111.39 Thousand USD | 12.86% |
| 2001 Q2 | 475.99 Thousand USD | 88.93% |
| 2001 Q4 | 98.7 Thousand USD | 244.52% |
| 2001 Q3 | 28.64 Thousand USD | -93.98% |
| 2001 FY | 98.7 Thousand USD | 120.81% |
| 2001 Q1 | 251.93 Thousand USD | 153.13% |
| 2000 FY | -474.21 Thousand USD | 68.39% |
| 2000 Q1 | -3.2 Million USD | -113.33% |
| 2000 Q2 | -2.4 Million USD | 25.0% |
| 2000 Q4 | -474.21 Thousand USD | 66.78% |
| 2000 Q3 | -1.42 Million USD | 40.51% |
| 1999 Q3 | -1.5 Million USD | 6.25% |
| 1999 Q4 | -1.5 Million USD | 0.0% |
| 1999 Q2 | -1.6 Million USD | 5.88% |
| 1999 Q1 | -1.7 Million USD | 0.0% |
| 1999 FY | -1.5 Million USD | 11.76% |
| 1998 Q4 | -1.7 Million USD | -6.25% |
| 1998 FY | -1.7 Million USD | -30.77% |
| 1998 Q1 | -1.5 Million USD | -15.38% |
| 1998 Q2 | -1.5 Million USD | 0.0% |
| 1998 Q3 | -1.6 Million USD | -6.67% |
| 1997 Q1 | -300 Thousand USD | -250.0% |
| 1997 FY | -1.3 Million USD | -750.0% |
| 1997 Q4 | -1.3 Million USD | 18.75% |
| 1997 Q3 | -1.6 Million USD | -166.67% |
| 1997 Q2 | -600 Thousand USD | -100.0% |
| 1996 Q1 | 800 Thousand USD | 33.33% |
| 1996 Q4 | 200 Thousand USD | 100.0% |
| 1996 Q3 | 100 Thousand USD | -75.0% |
| 1996 FY | 200 Thousand USD | -66.67% |
| 1996 Q2 | 400 Thousand USD | -50.0% |
| 1995 Q4 | 600 Thousand USD | 20.0% |
| 1995 FY | 600 Thousand USD | -40.0% |
| 1995 Q2 | 800 Thousand USD | -20.0% |
| 1995 Q3 | 500 Thousand USD | -37.5% |
| 1995 Q1 | 1 Million USD | 0.0% |
| 1994 Q1 | 1.7 Million USD | -10.53% |
| 1994 Q2 | 1.4 Million USD | -17.65% |
| 1994 FY | 1 Million USD | -47.37% |
| 1994 Q3 | 1.5 Million USD | 7.14% |
| 1994 Q4 | 1 Million USD | -33.33% |
| 1993 Q2 | 1.5 Million USD | -16.67% |
| 1993 Q4 | 1.9 Million USD | 5.56% |
| 1993 FY | 1.9 Million USD | -5.0% |
| 1993 Q1 | 1.8 Million USD | -10.0% |
| 1993 Q3 | 1.8 Million USD | 20.0% |
| 1992 Q3 | 2.3 Million USD | -14.81% |
| 1992 Q2 | 2.7 Million USD | 0.0% |
| 1992 Q4 | 2 Million USD | -13.04% |
| 1992 FY | 2 Million USD | -20.0% |
| 1992 Q1 | 2.7 Million USD | 8.0% |
| 1991 FY | 2.5 Million USD | -10.71% |
| 1991 Q4 | 2.5 Million USD | -3.85% |
| 1991 Q3 | 2.6 Million USD | 8.33% |
| 1991 Q2 | 2.4 Million USD | -4.0% |
| 1991 Q1 | 2.5 Million USD | -10.71% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | 2.8 Million USD | 0.0% |
| 1990 FY | 2.8 Million USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | - USD | 100.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 112.499% |
| BrainsWay Ltd. | -10.32 Million USD | 67.2% |
| Cerus Corporation | 84.35 Million USD | 104.013% |
| Envoy Medical, Inc. | -3.81 Million USD | 11.248% |
| electroCore, Inc. | -9.95 Million USD | 65.997% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 33.951% |
| IceCure Medical Ltd | -9.93 Million USD | 65.925% |
| Inogen, Inc. | -103.56 Million USD | 96.732% |
| OrthoPediatrics Corp. | -9.26 Million USD | 63.473% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 7.031% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 74.154% |
| MaxCyte, Inc. | -27.76 Million USD | 87.808% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 34.12% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -487.911% |
| Orthofix Medical Inc. | 96.44 Million USD | 103.51% |
| PAVmed Inc | 29.08 Million USD | 111.638% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 80.017% |
| RxSight, Inc. | -6.68 Million USD | 49.326% |
| Sight Sciences, Inc. | -102.71 Million USD | 96.704% |
| SI-BONE, Inc. | 5.72 Million USD | 159.168% |
| TELA Bio, Inc. | -3.94 Million USD | 14.282% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 105.905% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1061.648% |
| Acutus Medical, Inc. | 12.27 Million USD | 127.567% |
| Talis Biomedical Corporation | -57.06 Million USD | 94.068% |
| Spectral AI, Inc. | -3.5 Million USD | 3.313% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 92.952% |
| CVRx, Inc. | -59.95 Million USD | 94.354% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 270.602% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 364.942% |
| Bioventus Inc. | 372.51 Million USD | 100.909% |
| Venus Concept Inc. | 74.3 Million USD | 104.556% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 66.755% |
| LivaNova PLC | 62.53 Million USD | 105.413% |
| 908 Devices Inc. | -115.09 Million USD | 97.059% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.055% |
| Nemaura Medical Inc. | 9.92 Million USD | 134.106% |
| NeuroPace, Inc. | 54.33 Million USD | 106.23% |
| LENSAR, Inc. | -18.31 Million USD | 81.515% |
| Apyx Medical Corporation | -5.15 Million USD | 34.285% |
| Cutera, Inc. | 288.3 Million USD | 101.174% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 145.043% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1391.985% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 92.277% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 63.203% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.241% |
| Axonics, Inc. | -77.19 Million USD | 95.615% |
| Outset Medical, Inc. | 67.67 Million USD | 105.002% |
| IRIDEX Corporation | -4.28 Million USD | 21.059% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.099% |
| IRadimed Corporation | -47.71 Million USD | 92.906% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -11.864% |
| INVO Bioscience, Inc. | 8.45 Million USD | 140.054% |
| Telesis Bio, Inc. | 32.63 Million USD | 110.372% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -35.285% |
| Varex Imaging Corporation | 316.9 Million USD | 101.068% |
| Quipt Home Medical Corp. | 81.73 Million USD | 104.141% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -21.675% |
| Pulmonx Corporation | -42.36 Million USD | 92.009% |
| Dynatronics Corporation | 6.2 Million USD | 154.561% |
| Modular Medical, Inc. | -8.04 Million USD | 57.908% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 21.224% |
| Semler Scientific, Inc. | -57.13 Million USD | 94.075% |
| InMode Ltd. | -135.39 Million USD | 97.5% |
| Bruker Corporation | 891.3 Million USD | 100.38% |
| Cytosorbents Corporation | 4.18 Million USD | 180.942% |
| DexCom, Inc. | 2.02 Billion USD | 100.167% |
| Align Technology, Inc. | -840.47 Million USD | 99.597% |
| Viveve Medical, Inc. | -13.81 Million USD | 75.494% |
| ZimVie Inc. | 450.41 Million USD | 100.752% |
| Movano Inc. | -5.86 Million USD | 42.295% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 97.482% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -487.911% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 270.602% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.949% |
| Profound Medical Corp. | -18.17 Million USD | 81.379% |
| Insulet Corporation | 798.1 Million USD | 100.424% |
| enVVeno Medical Corporation | -2.21 Million USD | -52.615% |
| Surmodics, Inc. | -12.01 Million USD | 71.825% |
| iCAD, Inc. | -21.2 Million USD | 84.04% |
| Nuwellis, Inc. | -2.81 Million USD | -20.078% |
| Biotricity, Inc. | 23.09 Million USD | 114.658% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 103.614% |
| Aethlon Medical, Inc. | -4.5 Million USD | 24.806% |
| InspireMD, Inc. | -8.04 Million USD | 57.924% |
| PAVmed Inc. | 29.08 Million USD | 111.638% |
| BIOLASE, Inc. | 11.34 Million USD | 129.84% |
| Beyond Air, Inc. | 6.22 Million USD | 154.343% |
| FONAR Corporation | -14.66 Million USD | 76.918% |
| AxoGen, Inc. | 32.26 Million USD | 110.491% |
| Vivani Medical, Inc. | 42 Thousand USD | 8159.524% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 68.24% |
| Inari Medical, Inc. | -7.16 Million USD | 52.73% |
| UFP Technologies, Inc. | 40.77 Million USD | 108.302% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 210.31% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 29.055% |
| Tenon Medical, Inc. | -1.25 Million USD | -169.721% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 55.496% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 71.617% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.153% |
| Sintx Technologies, Inc. | 905 Thousand USD | 474.033% |
| NanoVibronix, Inc. | -3.27 Million USD | -3.264% |
| Quanterix Corporation | -132.95 Million USD | 97.454% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -21.675% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 84.865% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.449% |
| TransMedics Group, Inc. | 121.13 Million USD | 102.794% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 87.07% |
| NeuroMetrix, Inc. | -1.49 Million USD | -127.018% |
| Hyperfine, Inc. | -75.61 Million USD | 95.524% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.224% |
| Bone Biologics Corporation | -3.02 Million USD | -11.843% |
| AVITA Medical, Inc. | -26.23 Million USD | 87.096% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -84.126% |
| Silk Road Medical, Inc | 64.42 Million USD | 105.254% |